CHEBI:82978 - paliperidone

ChEBI IDCHEBI:82978
ChEBI Namepaliperidone
Stars
DefinitionA racemate comprising equimolar amounts of (R)- and (S)-paliperidone. Paliperidone is the primary active metabolite of the older antipsychotic risperidone and is used for treatment of schizophrenia.
Last Modified22 February 2017
Submittertmorrison
FormulaC23H27FN4O3
Net Charge0
Average Mass426.484
Monoisotopic Mass426.20672
Wikipedia
Roles Classification
Biological Roles:
serotonergic antagonist  Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
H1-receptor antagonist  H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
alpha-adrenergic antagonist  An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
dopaminergic antagonist  A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
Applications:
neuroprotective agent  Any compound that can be used for the treatment of neurodegenerative disorders.
serotonergic antagonist  Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
psychotropic drug  A loosely defined grouping of drugs that have effects on psychological function.
H1-receptor antagonist  H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
alpha-adrenergic antagonist  An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
second generation antipsychotic  Antipsychotic drugs which can have different modes of action but which tend to be less likely than first generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements.
dopaminergic antagonist  A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
ChEBI Ontology
Outgoing Relation(s)
paliperidone (CHEBI:82978) has part (R)-paliperidone (CHEBI:83806)
paliperidone (CHEBI:82978) has part (S)-paliperidone (CHEBI:83805)
paliperidone (CHEBI:82978) has role dopaminergic antagonist (CHEBI:48561)
paliperidone (CHEBI:82978) has role drug metabolite (CHEBI:49103)
paliperidone (CHEBI:82978) has role H1-receptor antagonist (CHEBI:37955)
paliperidone (CHEBI:82978) has role neuroprotective agent (CHEBI:63726)
paliperidone (CHEBI:82978) has role psychotropic drug (CHEBI:35471)
paliperidone (CHEBI:82978) has role second generation antipsychotic (CHEBI:65191)
paliperidone (CHEBI:82978) has role serotonergic antagonist (CHEBI:48279)
paliperidone (CHEBI:82978) has role α-adrenergic antagonist (CHEBI:37890)
paliperidone (CHEBI:82978) is a racemate (CHEBI:60911)
IUPAC Name 
rac-3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
INN  Source
paliperidoneKEGG DRUG
Synonyms  Source
Ro-76477DrugBank
9-HydroxyrisperidoneDrugBank
RO76477ChemIDplus
rac-paliperidoneChemIDplus
racemic paliperidoneChemIDplus
9-hydroxy-risperidoneChemIDplus
Brand Name  Source
InvegaKEGG DRUG
Manual XrefsDatabases
D05339KEGG DRUG
DB01267DrugBank
HMDB0015396HMDB
PaliperidoneWikipedia
Registry NumbersSources
Reaxys:8808385Reaxys
CAS:144598-75-4KEGG DRUG
CAS:144598-75-4ChemIDplus
Citations